Status:
UNKNOWN
Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis:
Lead Sponsor:
University of Nove de Julho
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
Background: Multiple sclerosis (MS) is an autoimmune disease, for which the forms of treatment are medication and rehabilitation. However, in vitro and in vivo studies have demonstrated that photobiom...
Eligibility Criteria
Inclusion
- Diagnosis of MS;
- Age between 18 and 60 years;
- Currently undergoing pharmacological treatment;
- Capable of understanding and following verbal instructions;
- score of \< 7 on the Expanded Disability Status Scale;
- No restriction will be imposed regarding gender.
Exclusion
- Other autoimmune diseases;
- Neoplasias;
- Heart failure;
- Respiratory failure;
- Renal insufficiency;
- Hepatic insufficiency;
- Acquired immunodeficiency syndrome;
- Patients with relapses of the disease will be excluded from the study.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2019
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03360487
Start Date
January 1 2018
End Date
February 28 2019
Last Update
October 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNINOVE
São Paulo, São Paulo, Brazil, 01504-001